GlassScriptPhysician profile
Clare Petty
NPI 1366622185
$309.17
in general payments reported to CMS, 2019-2025
9 companies · $93.13 in 2025
The $93.13 reported for 2025 was less than what a typical Family provider received nationally (typical 2025 total: $167).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2023: $156 · 2024: $60.14 · 2025: $93.13.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $309.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $309.17 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $82.01 | 2023-2025 | |
| Amgen INC. | $38.92 | 2025 | Evenity |
| Pfizer INC. | $37.13 | 2023-2024 | |
| Novo Nordisk INC | $33.45 | 2023 | Ozempic, Rybelsus |
| Glaxosmithkline, LLC. | $31.85 | 2023-2024 | Shingrix, Arexvy |
| Exact Sciences Corporation | $29.58 | 2023 | Cologuard Collection Kit |
| Lilly USA, LLC | $28.56 | 2023 | Jardiance, Emgality |
| E.R. Squibb & Sons, L.L.C. | $14.00 | 2025 | Camzyos |
| Sanofi Pasteur INC. | $13.67 | 2023 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Clare Petty listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.